Literature DB >> 5007072

Menstrual blood loss and fibrin degradation products.

S K Cole, A R Clarkson.   

Abstract

As part of a large-scale study of menstrual blood loss in the community serum fibrin degradation products were measured soon after menstruation in 331 women. No significant correlation was found between the amount of blood lost and the serum level of fibrin degradation products. These findings conflict with reports suggesting that excessive intrauterine fibrinolysis, which may play a part in menorrhagia, is associated with raised serum F.D.P. concentrations.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5007072      PMCID： PMC1789286          DOI： 10.1136/bmj.1.5792.78

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  14 in total

1.  Coagulation studies in the hyperacute and other forms of renal-allograft rejection.

Authors:  R W Colman; W E Braun; G J Busch; G J Dammin; J P Merrill
Journal:  N Engl J Med       Date:  1969-09-25       Impact factor: 91.245

2.  Fibrin degradation products in sera of women with normal menstruation and menorrhagia.

Authors:  H K Basu
Journal:  Br Med J       Date:  1970-01-10

3.  Comparison of chemical and atomic absorption methods for estimating menstrual blood loss.

Authors:  G A Cheyne; M M Shepherd
Journal:  J Med Lab Technol       Date:  1970-07

4.  Treatment of menorrhagia.

Authors:  L Nilsson; G Rybo
Journal:  Am J Obstet Gynecol       Date:  1971-07-01       Impact factor: 8.661

5.  Serum and urinary fibrin-fibrinogen degradation products in glomerulonephritis.

Authors:  A R Clarkson; M K MacDonald; J J Petrie; J D Cash; J S Robson
Journal:  Br Med J       Date:  1971-08

6.  Urinary fibrin-fibrinogen degradation poducts after renal homotransplantation.

Authors:  A R Clarkson; J B Morton; J D Cash
Journal:  Lancet       Date:  1970-12-12       Impact factor: 79.321

7.  Plasminogen activators in the endometrium. II. Clinical aspects. Variation in the concentration of plasminogen activators during the menstrual cycle and its relation to menstrual blood loss.

Authors:  G Rybo
Journal:  Acta Obstet Gynecol Scand       Date:  1966       Impact factor: 3.636

8.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

9.  Fibrin degradation products in sera of normal subjects.

Authors:  P C Das; A G Allan; D G Woodfield; J D Cash
Journal:  Br Med J       Date:  1967-12-23

10.  Investigations and preparation of fibrinogencoated tan A/Das PC: Investigations and preparation of fibrinogen-coated tanned sheep red cells.

Authors:  P C Das
Journal:  J Clin Pathol       Date:  1970-03       Impact factor: 3.411
View more
  2 in total

Review 1.  Clinical applications of fibrinolytic inhibition in gynaecology.

Authors:  J Bonnar; J Guillebaud; J M Kasonde; B L Sheppard
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

Review 2.  Endometrial haemostasis and menstruation.

Authors:  Joanna Davies; Rezan A Kadir
Journal:  Rev Endocr Metab Disord       Date:  2012-12       Impact factor: 6.514
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.